Tech Company Financing Transactions
Tryton Medical Funding Round
Tryton Medical, operating out of Durham, raised $20 million from 3x5 Special Opportunity Partners, Canepa Advanced Healthcare Fund and RiverVest Venture Partners.
Transaction Overview
Company Name
Announced On
9/8/2014
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The Company will use these proceeds to complete enrollment in the Tryton IDE Extended Access Registry, to support our U.S. Food and Drug Administration (FDA) submission, and to develop the left main market opportunity with the CE approved left main stent indication for our Tryton Side Branch Stent.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
1000 Park Forty Plaza 325
Durham, NC 27713
USA
Durham, NC 27713
USA
Phone
Website
Email Address
Overview
Tryton Medical, Inc. is the leading developer of stents that are designed to definitively treat bifurcation lesions. 540,000 bifurcation coronary lesions are sub-optimally treated every year with a variety of time consuming and technically challenging procedures.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Carl Bernard
Chief Financial Officer
Brett Farabaugh
Chief Medical Officer
Aaron Kaplan
Chief Operating Officer
Richard Davis
VP - Regulatory Affairs
Douglas Ferguson
Browse more venture capital transactions:
Prev: 9/8/2014: Eiger BioPharmaceuticals venture capital transaction
Next: 9/8/2014: Wellframe venture capital transaction
Share this article
About Our VC Transactions Data
Our team works diligently to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs